[Asia Economy Reporter Ryu Taemin] Inbiogen announced on the 31st that it has decided on a paid-in capital increase worth 23.3 billion KRW.



This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing